Clinical Trials Browser

Phase 1 × Central Nervous System Neoplasms × Influenza Vaccines × Clear all

NCT01941758 2018-07-05

High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors

Phase 1 Completed

Central Nervous System Neoplasms